Biogen Inc.
BIIBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3058% above fair value
$249.59+2.46 (+1.00%)
Close on Nov 20, 2026Market cap $36.89BP/E 106.7Yield –
Biogen Inventories, Net (Current): $2,224M in Q3 2026, up 0.7% from a year earlier.
Latest, Q3 2026
2,224
Period ended Sep 30, 2026
Change on a year earlier
+0.7%
2,209 in Q3 2025
History
47 quarters
Since Q1 2015
Sources
46
Documents cited below
Where the Q3 2026 figure comes from
Source: Biogen Form 10-Q (filed 2026-10-28) ↗
Reported in Form 10-Q/10-K Inventories Note (XBRL).
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up inventories, Net (Current)
Cite this data
StockData. (2026). Biogen Inventories, Net (Current) ($M), quarterly Q1 2015–Q3 2026 [Data set]. Compiled from Biogen SEC filings and investor materials. https://stockdatahq.com/stocks/biib/kpis/inv-net-current
See every metric in the Biogen KPI table. Data updated Nov 10, 2026.
See a number that looks wrong?